IOF Blog
Patients Guide to Cell Based Therapy in Orthopedics
The Interventional Orthobiologics Foundation (IOF) was founded on the idea that the future of medicine is regenerative.
Interventional Orthobiologic medicine focuses on precise injection of orthobiologics under image guidance. These regenerative biologic treatments, like adult stem cell therapy and platelet rich plasma, require a level of expertise to perform.
A Patient’s Guide to Cell Based Therapy in Orthopedics
ACTION REQUIRED for physicians who use either PRP or BMAC
IOF Member of the Week: Dr. Christopher Rogers
IOF Member of the Week: Dr. Paras Shah
IOF Member of the Week: Dr. Alberto Panero
IOF Member of the Week: Dr. Matthew Hyzy
Adipose/Fat Therapy Evidence
IOF Member of the Week: Dr. Rahul Desai
IOF Member of the Week: Dr. John Pitts
IOF Member of the Week: Dr. Leiber
IOF Member of the Week: Dr. Robert Kramberg
IOF Member of the Week: Dr. Jason Markle
IOF Member of the Week: Dr. Christopher J. Centeno
IOF Member of the Week: Dr. Henry Stiene
IOF Member of the Week: Dr. Chris Williams
IOF Regulatory Warning: Exosome Products
Case Study: Cervical Spine Fusion Treated with PRP
IOF Launches Ethics Committee; How to Report Unlawful Sale of Medical Products
FDA Response Regarding Chara Biologics Products
IOF Expands Course Offerings to Florida and Washington
Statement from IOF President on the New York Times Article “An Unproven Cure”
IOF 2019 Conference Videos Available for Purchase
IOF President Receives $590,000 Award to Treat Meniscal Injuries in Military Personnel
Dr. Ariana DeMers Joins the IOF Board
FDA Warning
Birth Tissue Products Consensus and IOF Webinar Recording
Q&A with IOF Instructor Dr. James Leiber
Your Right to Use Autologous Orthobiologics May be Threatened
Can Platelet Rich Plasma (PRP) Regenerate a Degenerative Disc?
Learn About Platelet Rich Plasma (PRP) Dosage in Tendons at #IOF2017
If you’re using 3-5X PRP in tendons you may be under dosing certain patients.
Two articles have been published suggesting that higher concentrations of PRP cause tenocyte inhibition. Given that both studies had serious design flaws, Interventional Orthopedics Foundation (IOF) scientists repeated these experiments.
Interventional Orthopedics Foundation Announces Fellowship Grants
Regenerative Orthopedics Offer New Hope to Injured Soldiers
Future of Personal Health reports on how regenerative orthopedic procedures are helping soldiers recover from traumatic injuries.
Summary of Patient Registry Database Statistics and Benefits
Wounded Warrior Program Update
Platelet Rich Plasma (PRP) and Why the IOF is Studying its Effects on Cultured Cells
Interventional Orthopedics Foundation Receives Additional Funding to Further Advance the Organization
Companies Respond to IOF Findings Related to Placental Tissue-Derived Products
A reference for information regarding placental derived products. This data includes company follow-up and statements / responses to our December 16, 2015 press release regarding an absence of stem cells in placental tissue-derived products.
Interventional Orthopedics Foundation Shines Light on False Claims about Stem Cell Products
In Vitro Evaluation of Injectable, Placental Tissue-Derived Products for Orthopedic Applications
2015 Fellowship Grants Awarded!
Contact Us
IOF Training Center:
403 Summit Blvd
Broomfield, CO 80021
IOF Business Office:
3801 E. Florida Ave #635
Denver, CO 80210
Phone: 303-469-4431
Fax: 303-479-2608
